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Abstract
PE_PGRS represent a large family of proteins typical of pathogenic mycobacteria whose
members are characterized by an N-terminal PE domain followed by a large Gly-Ala repeat-
rich C-terminal domain. Despite the abundance of PE_PGRS-coding genes in theMyco-
bacterium tuberculosis (Mtb) genome their role and function in the biology and pathogene-
sis still remains elusive. In this study, we generated and characterized anMtb H37Rv
mutant (MtbΔ33) in which the structural gene of PE_PGRS33, a prototypical member of the
protein family, was inactivated. We showed that this mutant entered macrophages with an
efficiency up to ten times lower than parental or complemented strains, while its efficiency in
infecting pneumocytes remained unaffected. Interestingly, the lack of PE_PGRS33 did not
affect the intracellular growth of this mutant in macrophages. Using a series of functional
deletion mutants of the PE_PGRS33 gene to complement theMtbΔ33 strain, we demon-
strated that the PGRS domain is required to mediate cell entry into macrophages, with the
key domain encompassing position 140–260 amino acids of PE_PGRS33. PE_PGRS33-
mediated entry into macrophages was abolished in TLR2-deficient mice, as well as follow-
ing treatment with wortmannin or an antibody against the complement receptor 3 (CR3),
indicating that PE_PGRS33-mediated entry ofMtb in macrophages occurs through interac-
tion with TLR2.
Introduction
Tuberculosis (TB) is still one of the most relevant public health issues worldwide and primarily
in developing countries where it poses a tremendous health, economic and social burden [1].
Decisive prophylactic and therapeutic tools are still missing, in part because many aspects of
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TB pathogenesis and ofMycobacterium tuberculosis (Mtb) biology remain elusive [2,3]. In the
last two decades, a new understanding of this ancient disease has been gained following the
deciphering of theMtb genome [4], which uncovered unexpected and surprising features of
the tubercle bacilli [5,6]. The disclosure that almost 10% of theMtb genome coding capacity is
devoted to the mycobacterial-specific PE and PPE protein families raised much interest on
their role inMtb biology [7–10].
All PE proteins are characterized by a highly conserved N-terminal domain ofﬃ 100 amino
acids with the presence of a proline-glutamic acid (PE) motif at position 8–9 [4]. Out of the 99
PE genes found inMtbH37Rv [4], 63 were annotated as PE_PGRS though some of these were
pseudogenes or lacked some of the typical PE_PGRS features, so that only 51 PE_PGRS poten-
tially functional proteins are expressed [8]. PE_PGRSs proteins share the same molecular
architecture, characterized by the presence, beyond a PE domain, of i) a typical PGRS domain
varying in sequence and size containing a variable number of GGA-GGN repeats; ii) a highly
conserved putative transmembrane domain linking the PE and PGRS domains with a GRPLI
motif around position 115; iii) a unique C-terminal domain which is usually less than 30
amino acids long, but that in some cases (such as in PE_PGRS30) can be as large as 300 amino
acids [7,11,12]. PE_PGRS-encoding genes are found only in few mycobacterial species (M.
marinum,M. ulcerans and members of theMtb complex), are scattered throughout the
genome, and are differently regulated. The transcriptional regulation of some of them appears
to be finely tuned depending on the environmental signals encountered during the complex
steps of the infectious process, while others (as that encoding PE_PGRS33) are constitutively
expressed [7,8,13,14]. The paucity of experimental data on PE_PGRSs has so far hampered a
sufficient understanding of their role in TB pathogenesis.
PE_PGRS33 (Rv1818c), which can be considered a model for the family, is a 498 amino
acids protein whose PE domain mediates its translocation on the mycobacterial outer mem-
brane [15], and was used to deliver antigens on the mycobacterial surface [16–18]. Its surface
localization makes it available for interaction with host components, as suggested by studies
carried out with the avirulent vaccine strainMycobacterium bovis BCG [19]. Interestingly,
PE_PGRS33 was previously shown to trigger macrophage cell death by inducing secretion of
pro-inflammatory cytokines [20,21] and activation of pro-apoptotic or pro-necrotic signals
involving mitochondria [22–24]. Basu et al. [23] showed that PE_PGRS33 was capable of
inducing TLR2-dependent apoptosis in macrophages. All the studies aimed at investigating the
pro-inflammatory role of PE_PGRS33 were carried out by ectopically expressing PE_PGRS33
in the avirulent speciesM. smegmatis [20,21], by directly using the purified recombinant pro-
tein obtained in Escherichia coli [22,23] or by expressing the mycobacterial protein directly in
host cells using an eukaryotic expression plasmids [24].
In this study, we generated anMtb Rv1818c null mutant, which was complemented with a
series of Rv1818c genes manipulated to functionally dissect PE_PGRS33 structure. The result-
ing strains were used to investigate the role of PE_PGRS33 inMtb cell entry gaining insights in
the involvement of this protein in TB pathogenesis.
Material and Methods
Bacterial Strains
Mtb was grown at 37°C in Middlebrook 7H9 or 7H10 (Difco Becton-Dickinson), supple-
mented with 0.2% glycerol (Sigma-Aldrich), ADC 10% (Becton-Dickinson), and 0.05% v/v
Tween 80 (Sigma-Aldrich). The PE_PGRS33 mutant was generated inMtbH37Rv by allelic
exchange using the recombineering system [25]. Briefly, we constructed a pJSC-derivative vec-
tor, in which a region upstream Rv1818c (-563 to -1 bp) and a region internal to its coding
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sequence (561 to 1004 bp) were cloned at the flanks of an hygromycin cassette. The resulting
recombination substrate was digested, purified and introduced by electroporation inMtb
H37Rv competent cells containing pJV53, carrying the recombinases and conferring kanamy-
cin resistance. Transformants were first selected on 7H11/OADC-Tween 80 plates containing
hygromycin (50 μg ml-1) at 37°C for 3–4 weeks and selected colonies analyzed by PCR to dem-
onstrate Rv1818c deletion (S1 Fig). One mutant with the correct deletion was sub-cultured in
drug-free media for about 10 generations to allow the loss of pJV53 and then plated on solid
medium containing hygromycin at 37°C. Single colonies were picked and analyzed for loss of
the kanamycin resistance to isolates a mutant without pJV53. The Rv1818c null mutant was
then complemented using the integrative pMV306-derivative pAL79 [17] containing a copy of
Rv1818c gene fused with the sequence encoding the HA epitope under the control of its own
putative promoter (S2 Fig) [16].
Generation of PE_PGRS33 Functional Deletion Mutants for the PGRS
Domain
TheMtbH37Rv PE_PGRS33 hydrophobicity profile was obtained by in silico analysis using
the Kyte-Doolittle scale (CLC Main Workbench 6.9). Based on the hydrophobic/hydrophilic
characteristics at the C-terminal PGRS domain, four Rv1818c fragments encoding the first 472,
401, 341 and 260 amino acids, lacking variable size of the PGRS domain, were amplified from
theMtbH37Rv genome (using primers indicated in S1 Table) and cloned under the control of
the Rv1818c native promoter into the integrative plasmid pMV306 upstream and in frame
with the HA epitope sequence.
Cell Line Culture
The J774 cell line (murine macrophage) were grown in RPMI 1640 medium containing 10%
fetal calf serum (FCS) supplemented with glutamine (2 mM), streptomycin (100 μg/ml), peni-
cillin (100 U/ml), and sodium pyruvate (1 mM). Cells were kept in a humidified atmosphere
containing 5% CO2 at 37°C. The cells were diluted to 1.2 x10
6 per ml in 48 and 24-well plates
with 2% FCS. Human THP-1 monocytic cells were grown in RPMI 1640 supplemented with
glutamine (2 mM) and 10% FCS. Cells were treated with 20 nM PMA (Sigma-Aldrich,
St. Louis, MO) for 24 h to induce their differentiation into macrophage-like cells, then washed
three times with PBS and maintained in 2% FCS.
The human lung adenocarcinoma epithelial cell line, A549 (ATCC, Rockville, MD), were
used as model of human type II alveolar epithelial cells. Cells were grown in complete medium
consisting of RPMI 1640 supplemented with 10% FCS, 2 mM L-glutamine and 5 μg/ml of gen-
tamicin, and split when a confluent cell monolayer was attained [26].
Primary Murine Peritoneal Macrophages (pMM0)
C57BL/6 mice were purchased from Harlan (Italy) and maintained in pathogen-free micro-iso-
lator cages. The animals were housed in a temperature-controlled environment with 12 h light/
dark cycles, and received food and water ad libitum. All animal experiments were authorized
by the Ethical Committee of the Università Cattolica del Sacro Cuore (n°T21/2011) and per-
formed in compliance with the legislative decree of the Italian Government 27 January 1992, n.
116 and the Health Minister memorandum 14 May 2001, n. 6. All manipulations were per-
formed under isoflurane anesthesia, and all efforts were made to minimize suffering. Nine-
fourteen weeks-old female mice were euthanized by inhalation of isoflurane (Baxter, Warsaw,
Poland). Inflammatory peritoneal cells, elicited with 1 ml of aged 3% thioglycollate (Difco,
Detroit, MI), injected intraperitoneal 4–5 days earlier, were washed out with phosphate
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buffered saline (PBS) and collected into centrifuge tubes kept on ice. After washing once, peri-
toneal cells were re-suspended in the RPMI/FBS medium and plated at 1.2×106 cells/ml in
48-well tissue culture plates. Following overnight incubation, non-adherent cells were removed
by washing, whereas adherent macrophages were used for experiments. Similar procedures
were used to isolate pMM0 from TLR2-/- mice.
Mycobacterial Infection and Bacterial Counts In Vitro
Cells were infected with mycobacteria at different multiplicity of infection (MOI) and incu-
bated for 4 hours post-infection at 37°C in a 5% CO2 atmosphere. Cells were then washed three
times with PBS to remove extracellular bacteria and then incubated with complete RPMI 2% of
FCS without antibiotics. To assess the ability of theMtb strains to survive intracellularly, mac-
rophages were infected at different MOIs (1:10, 1:1 or 10:1) and infection in A549 cells was car-
ried at MOI of 5:1. Cells were washed with PBS three times to remove extracellular bacteria
and then incubated in fresh medium. At different time points, cells were lysed in 0.1% of Triton
X-100 and intracellular bacteria determined by CFU counting by serially diluting lysates in
PBS containing Tween80 (0.05%) and plating on 7H11/OADC agar plates [13]. Colony count-
ing was then performed in triplicate. In some cases, after infection the supernatant, containing
not internalized bacteria was collected and plated on 7H11/OADC agar plates.
pMM0 were treated before infection with wortmannin (Calbiochem, San Diego, CA) at the
concentration of 100 nM and 300 nM and with mAb anti-CR3 at final concentration of 10 μg/
ml (clone M1/70 BD, Biosciences) for 30 minutes at 37°C and then infected withMtb strains at
MOI 1:10 and intracellular bacteria counted as above. Statistical analysis to assess differences
between theMtbΔ33 mutants strains and parental and complemented strains was performed
using the Student’s t-test and ANOVA with GraphPad Prism software version 5.0 (GraphPad
software, CA, USA).
Results
Generation of an Rv1818c Mutant and Its Complementation
To investigate the role of PE_PGRS33 inMtb pathogenesis, inactivation of the Rv1818c gene
by recombineering [25] was carried out on theMtbH37Rv strain as shown in S1 Fig, to gener-
ate theMtbΔ33 mutant strain. The lack of an antibody specific for PE_PGRS33 prevented the
demonstration of the gene inactivation by immunoblot [27]. The mutant strain was comple-
mented by transformation with an integrative plasmid containing Rv1818c fused with the
sequence encoding the HA epitope, expressed from its own promoter [16,17] (S2 Fig). Expres-
sion of the PE_PGRS33HA in theMtbΔ33 complemented strain (MtbΔ33::PE_PGRS33HA) was
demonstrated by immunoblotting using an anti-HA antibody (S2 Fig). Conversely, from what
previously observed with the BCG mc21525 mutant, where inactivation of the Rv1818c was
obtained by transposon mutagenesis [19], no significant differences in the growth features of
theMtbH37Rv,MtbΔ33 andMtbΔ33::PE_PGRS33HA in solid media and liquid culture were
observed (data not shown). In any case, the lack of a phenotype in axenic culture for the
MtbΔ33 mutant provided a reliable model to investigate the role of PE_PGRS33 inMtb cell
entry.
PE_PGRS33 Is Required forMtb Cell Entry into Macrophages
Seminal studies showed that PE_PGRS33 is exposed on the surface and that lack of PE_PGRS33
in a BCG transposon insertion mutant prevents proper bacilli entry into host cells [19]. To
assess whether this was also true for virulentMtb, J774 murine macrophages were infected
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with H37Rv, theMtbΔ33 mutant and theMtbΔ33::PE_PGRS33HA complemented strain. The
mutant strain was strongly impaired in its ability to enter macrophages by a reduction of 1.3
Log CFU of intracellular bacteria after 4h of infection compared to wild type strain, (p<0.01),
although the intracellular replication rate of the mutant that entered macrophages was similar
to that of the parental or complemented strains (Fig 1A). Interestingly, when the infection was
repeated increasing the multiplicity of infection (MOI) of theMtbΔ33 mutant, keeping the
number of the parentalMtb strain constant, at 4h post-infection a similar number of intracellu-
lar bacteria for the two strains was found and their number increased after 7 days of infection
(Fig 1B).
The role of PE_PGRS33 inMtb entry was also confirmed in human monocyte-derived mac-
rophages (THP-1), withMtbΔ33 impaired in its ability to enter these cells (Fig 1C; - 0.99 Log
CFU in theMtbΔ33 compared to theMtbH37Rv parental strain; p<0.01), yet invading organ-
isms were still capable of intracellular replication as shown by intracellular CFUs measured
at day 7 (Fig 1A–1C). Taken together these results indicate that PE_PGRS33 significantly con-
tributes to the ability ofMtb to enter macrophages, but is dispensable forMtb intracellular
replication.
Interestingly, when the same experiments were performed in type II human pneumocytes
(A549) following usual experimental settings [26], no differences in the ability to infect these
cells were observed among the three strains (Fig 1D), suggesting that PE_PGRS33 is required
forMtb entry in macrophages but not in epithelial cells.
To further investigate the role of PE_PGRS33 inMtb cell entry, murine peritoneal macro-
phages (pMM0) from C57Bl/6 mice were infected withMtbH37Rv,MtbΔ33 andMtbΔ33::
PE_PGRS33HA and the number of intracellular and extracellular bacilli was assessed by CFU
counting. As shown in Fig 2, while most of theMtbΔ33::PE_PGRS33HA bacilli were detected
intracellularly, theMtbΔ33 mutant was primarily detected in the supernatant and an inverse
correlation among the twoMtb strains was observed, clearly indicating that viableMtbΔ33
mutant organisms are indeed impaired in their ability to enter these macrophages.
PE_PGRS33-MediatedMtb Cell Entrance in Macrophages Occurs
through Interaction with TLR2
A number of mycobacterial components are known to interact with TLR2, such as lipoarabino-
mannan (LAM), lipomannan (LM), phosphatidil-myo-inositol mannoside (PIM), the 19-kDa
lipoprotein [28]. The immunomodulatory properties of the mycobacterial surface protein
PE_PGRS33 were found to be dependent upon the ability of the protein to bind and trigger
TLR2 [22,23]. Interestingly, interactions of microbial ligands with TLR2 were shown to medi-
ate entry of certain bacteria into macrophages [29]. To establish whether PE_PGRS33-me-
diated entrance ofMtb in macrophages was dependent on TLR2, pMM0 isolated from wild
type and TLR2-deficient mice were infected with H37Rv,MtbΔ33 and the complemented
strain. As shown in Fig 3, no differences were observed betweenMtbΔ33 and the parental or
complemented strains in their ability to enter in TLR2-/- pMM0. These results demonstrate
that PE_PGRS33 mediates entrance ofMtb in macrophages in a TLR2-dependent mechanism.
PE_PGRS33 Activates the TLR2-Dependent Pro-Adhesive Pathway in
Macrophages
Interaction of bacterial surface components with TLR2 has been shown to trigger the pro-
adhesive pathway by enhancing the avidity of the CR3 receptor through the activity of phos-
phatidylinositol 3-kinase (PI3K) [30,31]. To investigate whether this was also the case in the
PE_PGRS33-mediated entrance ofMtb, pMM0 were previously treated with wortmannin, an
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inhibitor of PI3K [31]. As shown in Fig 4, pMM0 treated with wortmannin were impaired in
their ability to phagocytizeMtbΔ33::PE_PGRS33HA, but notMtbΔ33, compared to untreated
pMM0 indicating that inhibition of PI3K abolishes the PE_PGRS33-mediated entrance in mac-
rophages. Equally, incubation of pMM0 with an antibody directed against CR3 inhibited
entrance ofMtbΔ33::PE_PGRS33HA, but not ofMtbΔ33 into macrophages (Fig 4) providing
further evidences that the activation of TLR2 by PE_PGRS33 triggers the pro-adhesive pathway
which enhances CR3 avidity for mycobacteria. The PE_PGRS33-mediated entrance ofMtb in
macrophages was observed in opsonized and non-opsonized bacilli (data not shown) suggest-
ing that this phenomena is not restricted for non-opsonic entrance [32]. Further characteriza-
tion of theMtbΔ33 mutant, including in vivo studies, will provide insights on the role of
PE_PGRS33 in the early and late steps of the TB infectious process.
The PGRS Domain Encompassing Position 140–260 of the Protein Is
Responsible for PE_PGRS33-MediatedMtb Entry into Macrophages
In an attempt to identify the functional region(s) of PE_PGRS33 implicated in the entry ofMtb
into macrophages, we analyzed the protein hydrophobicity pattern (Fig 5A), which revealed
the presence of numerous hydrophobic regions intercalated by shorter hydrophilic segments,
primarily located in the PGRS domain and likely available onMtb surface for interaction with
TLR2 [16,17,23]. Based on these observations, four PE_PGRS33 gene fragments corresponding
Fig 1. MtbΔ33 is impaired in its ability to enter macrophages.Murine J774 macrophages (A and B), human monocyte-derived macrophages THP-1 (C)
and human type II pneumocytes A549 (D) were infected withMtbH37Rv,MtbΔ33 andMtbΔ33::PE_PGRS33 strains at a MOI 1:10 (A-C) or 5:1 (D) and
following incubation cells were washed and at the different time points intracellular bacteria were determined by CFU counting. In the experiment shown in
panel B, theMtbH37Rv was infected at MOI 1:10, while theMtbΔ33 at MOI 1:1. Results of one representative experiments from at least three assays are
shown (*p<0.,01). CFUs were expressed as mean ± SD and were analysed by two-way ANOVA followed by Bonferroni posttest.
doi:10.1371/journal.pone.0150800.g001
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to the sequences encoding the first 472, 401, 341 and 260 amino acid residues of PE_PGRS33
(PE_PGRS33472, PE_PGRS33401, PE_PGRS33341, PE_PGRS33260) were cloned in an integra-
tive plasmid under the transcriptional control of the native promoter. These sequences were
inserted in frame with the HA epitope sequence to demonstrate protein expression of the func-
tional deletion mutants by immunoblot (data not shown). These four plasmids and the plasmid
encoding the functional mutant lacking the entire PGRS domain (PE1818c) [17] were used to
complement theMtbΔ33 strain (Fig 5B). pMM0 cells were infected at a MOI of 1:10 withMtb
H37Rv,MtbΔ33,MtbΔ33::PE_PGRS33 and the panel of complemented strains and bacterial
Fig 2. Deletion of PE_PGRS33 gene is associated with a defect in bacterial entry in pMM0. pMM0were infected withMtb H37Rv,MtbΔ33 and
MtbΔ33::PE_PGRS33 strains at MOI 1:1 to measure the number of intracellular vs extracellular bacteria at 4h post infection. Results of one representative
experiments from at least three assays are shown (*p<0.05). CFUs were expressed as mean ± SD and were analysed by two-way ANOVA followed by
Bonferroni posttest.
doi:10.1371/journal.pone.0150800.g002
Fig 3. PE_PGRS33-mediatedMtb cell entry in macrophages occurs through interaction with TLR2.
pMM0 isolated from C57Bl/6 and syngeneic TLR2-/- mice were infected withMtbH37Rv,MtbΔ33 and
MtbΔ33::PE_PGRS33HA and intracellular CFUs were determined at 4h post-infection. Results of one
representative experiments of at least three assays are shown (**p<0,.01). CFUs were expressed as
mean ± SD and were analysed by two-way ANOVA followed by Bonferroni posttest.
doi:10.1371/journal.pone.0150800.g003
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entry was measured by counting intracellular mycobacteria at 4 hours post-infection. As
expected [17,23,33], complementation of theMtbΔ33 mutant with the plasmid expressing the
PE1818c domain only did not restore the wild type phenotype (Fig 5C). Conversely, comple-
mentation of the mutant strain with the four functional deletion mutants for the PGRS region
of PE_PGRS33 restored the wild type phenotype, with the only exception of theMtbΔ33::
PE_PGRS33401 strain. Taken together these results suggest that the protein domain of
PE_PGRS33 that contributes toMtb entry in macrophages resides within the first 260 amino
acids of the protein.
Discussion
The appearance and expansion of PE_PGRS genes in certain mycobacteria has been linked to
the acquisition of new pathogenetic properties that made these organisms capable of causing
disease in mammals [4,9]. Despite the great interest raised by these findings, studies aimed at
addressing the role of PE_PGRS proteins inMtb biology and TB pathogenesis are still limited
[34]. In a seminal work, the role of PE_PGRS33 was partially characterized in BCG, using a
strain were the PE_PGRS33 was inactivated by random mutagenesis [19]. In this work, we
extended these findings and further dissected the role of PE_PGRS33 in the virulent strain
Mtb. The results obtained demonstrate that PE_PGRS33 is required for efficientMtb cell entry
in macrophages, but not in type II pneumocytes, while is dispensable for bacilli intracellular
replication. PE_PGRS33-mediated entrance into macrophages is dependent upon the TLR2
receptor and this interaction occurs through the PGRS domain of the protein, specifically
involving the first 260 amino acids of PE_PGRS33. These results indicate that PE_PGRS33
plays a crucial role duringMtb infection and provide experimental evidences that shed some
light on the functional role of this protein in TB pathogenesis.
Lack of PE_PGRS33 was associated with an impaired ability of theMtbΔ33 mutant strain to
enter macrophages, probably because of a defect in bacterial attachment to host cells. This
defect was not observed during infection of A549 pneumocytes, whereMtb entry is mediated
Fig 4. PE_PGRS33 activates the TLR2-dependent pro-adhesive pathway in macrophages. pMM0 isolated from C57Bl/6 mice were incubated with
wortmannin or with an anti-CR3 antibody (M1/70), or left untreated, and then infected (MOI 1:10) withMtbΔ33 and the complemented strainMtbΔ33::
PE_PGRS33HA and intracellular CFUs were determined at 4h post-infection. Results of one representative experiments of at least three assays are shown
(*p<0,.001). CFUs were expressed as mean ± SD and were analysed by two-way ANOVA followed by Bonferroni posttest.
doi:10.1371/journal.pone.0150800.g004
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Fig 5. PE_PGRS33 encoding the first 260 amino acids is capable to mediate the entrance phenotype into macrophages. Schematic of PE_PGRS33
fragments (A-C). Truncated forms of Rv1818c were cloned downstream the native promoter PE_PGRS33 and in frame with the HA epitope sequence into
the integrative plasmid pMV306. A) Rv1818c gene and its native putative promoter located 134 nucleotides upstream the start codon. Schematic overview
showing PE_PGRS33 domains: PE domain (red stripped), transmembrane region (magenta dotted), PGRS domain (green netting), HA epitope (rose). The
hydrophobicity profile of PE_PGRS33 was obtained using CLCMain Workbench 6.9 (Kyte-Doolittle scale, window size 9). B) Stylized representation of full-
length PE_PGRS33, PE domain and the 472, 401, 341 and 260 amino acid in length fragments (blue lines). Cloning and protein information are reported
beside. C) pMM0 isolated from C57BL/6 mice were infected at a MOI of 1:10 withMtbH37Rv,MtbΔ33,MtbΔ33::PE_PGRS33HA and complemented strains
expressing the 4 PE_PGRS33 functional deletion mutants. Intracellular CFUs were enumerated at 4h post-infection. Results of one representative
experiment of at least three assays are shown. * p<0.05 forMtb H37Rv vsMtbΔ33::PE_PGRS33 401 and *** p<0.001 compared with forMtb H37Rv vs
MtbΔ33 andMtbΔ33::PE Rv1818c. CFUs were expressed as mean ± SD and were analysed by one-way ANOVA followed by Dunnett’s multiple comparison
test.
doi:10.1371/journal.pone.0150800.g005
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by molecules different from those involved during macrophages entry [35], thereby suggesting
a specific interaction of PE_PGRS33 with macrophage surface components. The reduction in
intracellular CFUs measured for theMtbΔ33 mutant was robust and similar to the reduction
observed when the most important macrophage receptors involved inMtb phagocytosis were
blocked by specific antibodies [36]. SinceMtb enters macrophages by receptor-mediated
phagocytosis [37] these results raised the possibility that PE_PGRS33 may directly interact
with a macrophage receptor.
Several major host-receptors are involved in phagocytosis ofMtb, such as complement
receptors (CR1, CR3 and CR4), the mannose receptor (MR) and the Fcγ receptors [37]. Fcγ is
known to play a role in the presence of specific antibodies and entry via this receptor is
expected to generate a vigorous host response [36]. Lipoarabinomannans, mannans and man-
noproteins present on theMtb surface are accessible to the MR and contribute to the adhesion
of the bacilli to macrophages [38]. The MR also mediates uptake of mycobacteria other than
Mtb [39], which do not express any PE_PGRS protein and therefore, in our view, it is unlikely
that PE_PGRS33-mediated phagocytosis occurs through interaction with MR.
In previous studies [15] we showed that overexpression of PE_PGRS33 impacts on cell mor-
phology and modifies the surface of bacilli. It may be hypothesized that lack of PE_PGRS33
may alter the proper conformation and/or the composition of mycobacterial surface constitu-
ents, such as for instance LAM or other non-proteinaceous components involved inMtb cell
entry and activation of pro-inflammatory cytokines secretion through CD14 and TLR2 [40–
43]. In this scenario, the effects observed following overexpression of PE_PGRS33, or in its
absence, might be considered simple epiphenomena. However, we did not observe any major
difference in the cell morphology of theMtbΔ33 compared with the wild type and comple-
mented strains. It remains to be determined the causes of the differences observed between the
mutants of PE_PGRS33 obtained in BCG [19] andMtb, although immunoblot analysis with an
anti-PGRS antibody of the total cell fractions of BCG andMtb showed differences in the pro-
tein profile, suggesting that PE_PGRS expression and eventually localization in these two
mycobacteria might be different [27].
The results obtained with theMtbΔ33 complemented with the wild type gene PE_PGRS33
(MtbΔ33::PE_PGRS33HA) and theMtbΔ33::PE1818c, indicate that the PE domain of
PE_PGRS33 does not contain the information sufficient to mediate PE_PGRS33-mediated
entry in macrophages, in line with previous findings [19,23,33]. In an attempt to identify the
domain, within the PGRS region, responsible for the observed phenotype a panel of functional
deletion mutants expressing PE_PGRS33 protein missing fragments of increasing size of the
C-terminal domain were generated (Fig 5). Interestingly, complementation of the wild type
phenotype was obtained even with the mutant expressing the first 260 amino acids of the pro-
tein, which contains only a relatively small part of the PGRS domain. These results suggest that
the PGRS domain residing between position 140 and 260 of the protein contains the informa-
tion sufficient to interact with TLR2. The finding that the mutantMtbΔ33::PE_PGRS33401
could only partially complement the phenotype, suggests that folding of the downstream
domain of the PGRS is critical for the proper exposure of the first 260 amino acids of
PE_PGRS33. Sequencing of the PE_PGRS33 gene inMtb clinical isolates indicated that most
of the genetic polymorphisms resides in the PGRS region, but mainly downstream of the first
260 amino acids [44–46], somehow supporting the key role of this domain. Dissecting the
impact on function of these naturally occurring PE_PGRS alleles will be important to under-
stand the role of the PGRS domain, from a pathogenetic and evolutionary perspective.
Using purified recombinant PE_PGRS33 protein obtained in E. coli, Basu et al. showed that
PE_PGRS33 interacts directly with TLR2 ectopically expressed in RAW 264.7 or HEK293 cells;
that triggering of TNF-α was dependent on the PGRS domain and that variations in the
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polymorphic repeats of the PGRS domain differentially modulated TNF-α secretion [23].
Recent data obtained in our laboratory, in the model of ectopic expression inM. smegmatis,
demonstrated that PE_PGRS33-dependent TNF-α secretion in macrophages is dependent on
TLR2 [33], thereby suggesting that PE_PGRS33 may indeed interact with TLR2 on the macro-
phage surface. Remarkably, the defect in macrophage entry observed for theMtbΔ33 could not
be observed when pMM0 from TLR2-deficient mice were used, suggesting that PE_PGRS33-
mediated entry ofMtb into macrophages is likely dependent on a direct interaction of
PE_PGRS33 with TLR2. Unfortunately, the lack of any information on the structure of
PE_PGRS33, or of any other PE_PGRS protein, prevents to hypothesize the mechanism of
interaction with TLR2 [47].
The involvement of TLR2 in bacterial cell entry in macrophages has been proposed for sev-
eral pathogens. Recognition through the CD14 of the Porphyromonas gingivalis fimbriae acti-
vates a TLR2-dependent signalling pathway promoting binding to and internalization by
macrophages [48,49]. Interaction of these fimbriae with the CD14/TLR2 complex was shown
to induce a PI3K-mediated inside-out signalling that activates the ligand-binding capacity of
the CR3 and entry through CR3 was known to promote bacterial survival and virulence
[31,48,50,51]. Similarly, it has been shown that Bacillus anthracis spores contain an hair-like
nap formed by a glycoprotein that, by interacting with the CD14/TLR2 present on macro-
phages surface, activates the PI3K inside-out signalling pathway that enhances spore internali-
zation by increasing the avidity of the Mac-1 integrin [52]. The relevance of this inside-out
signalling, involving CD14, TLR2, PI3K and cytohesin and leading to the conversion of the low
avidity CR3 into an active receptor, has been demonstrated also for mycobacteria [53,54]. The
results of this study, indicating that treatment of pMM0 with a PI3K inhibitor wortmannin or
with the anti-CR3 antibody abolishes the PE_PGRS33-mediated entrance in macrophages (Fig
5), suggest that interaction of PE_PGRS33 with TLR2 activates the pro-adhesive pathway.
While the mechanism of PE_PGRS33-mediated entrance needs to be better defined, it can be
hypothesized that interaction of PE_PGRS33 with the TLR2 on macrophages in the early steps
of infection activates an inside-out signalling which contributes toMtb entry through the CR3
receptor.
This hypothesis is consistent with the TLR2-dependent pro-inflammatory properties of
PE_PGRS33 that have been demonstrated by several studies [20,22,23,33]. In fact, it has been
shown that P. gingivalis fimbriae induced two distinct TLR2 pathways mediating pro-inflam-
matory and pro-adhesive effects [30] and, more recently, that a fine tuning of the TLR2-CR3
crosstalk mediates inflammation and phagocytosis during Francisella tularensis infection [55].
In this scenario, PE_PGRS33 may be considered one of theMtb proteins that plays a relevant
role in the host-pathogen interplay, by fine tuning fundamental biological processes that can
impact the outcomes of infection.
The relevance of PE_PGRS33 forMtb pathogenesis can be inferred from the results
obtained following genomic analysis of smooth tubercle bacilli [56]. The gene encoding
PE_PGRS33 was found only in the MTBC genome but not in the smooth tubercle bacilli
genome, and PE_PGRS33 was not found inM.marinum, despite the large number of
PE_PGRS genes present in the genome of this mycobacterium [56]. The authors concluded
that the PE_PGRS33 structural gene was inserted in MTBC next to the Rv1817 gene [56] and
may thus have contributed to the acquistion of the specific pathogenic properties that made
MTBC a highly successfull global pathogen.
In a previous study [11], we showed that the PGRS domain of PE_PGRS30 is involved in
the arrest of phagosome acidification and inMtb growth inside macrophages, while it is not
involved in the entry of the bacteria inside macrophages. In this work, we demonstrate that the
PGRS domain of PE_PGRS33 is involved in the bacterial entry in macrophages, but not in
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their intracellular replication. The reason why two very similar domains can be involved in so
different cellular functions is still totally unknown and suggests that, despite the high similarity
and redundancy of the GGA-GGN repeats, PE_PGRS proteins can be involved in a wide range
of functions inMtb pathophysiology.
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